DiaMedica Therapeutics, Inc. (DMAC)
6.76
-0.26
(-3.70%)
USD |
NASDAQ |
Mar 20, 16:00
6.78
+0.02
(+0.30%)
After-Hours: 20:00
DiaMedica Therapeutics Total Liabilities (Quarterly) : 5.425M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 71.53B |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.05M |
| Shareholders Equity (Quarterly) | 51.62M |
| Debt to Equity Ratio | 0.0052 |
| Current Ratio | 10.67 |
| Net Debt Paydown Yield | 0.01% |